The ING4 Binding with p53 and Induced p53 Acetylation were Attenuated by Human Papillomavirus 16 E6

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Guo, Yi ^a   Meng, Xiangkai ^a   Wang, Qian ^a   Wang, Yanan ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN ING4; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; E6 GENE; GENE FUNCTION; GENE INTERACTION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; ING4 GENE; NONHUMAN; P53 GENE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION;

ACETYLATION; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84881504866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071453     Document Type: Article

References (38)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
2. zur Hausen H, (2002) Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2: 342-350.
3. Zuna RE, Allen RA, Moore WE, Mattu R, Dunn ST, (2004) Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod Pathol 17: 1314-1322.
4. zur Hausen H, (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst 92: 690-698.
5. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM, (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
6. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM, (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
7. Nakagawa S, Huibregtse JM, (2000) Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol 20: 8244-8253.
8. Kühne C, Banks L, (1998) E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J Biol Chem 273: 34302-34309.
9. Gao Q, Kumar A, Singh L, Huibregtse JM, Beaudenon S, et al. (2002) Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res 62: 3315-3321.
10. Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias KE, Schwartz AL, et al. (1998) Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci USA 95: 8058-8063.
11. Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, et al. (2005) The E6-AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem 280: 10807-10816.
12. Shai A, Nguyen ML, Wagstaff J, Jiang YH, Lambert PF, (2007) HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Oncogene. 26: 3321-3328.
13. Nakagawa S, Watanabe S, Yoshikawa H, Taketani Y, Yoshiike K, et al. (1995) T. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro. Virology 212: 535-542.
14. Wang H, Mo P, Ren S, Yan C, (2010) Activating Transcription Factor 3 Activates p53 by Preventing E6-associated Protein from Binding to E6. J Biol Chem 285: 13201-13210.
15. Chen JJ, Reid CE, Band V, Androphy EJ, (1995) Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269: 529-531.
16. Lee SS, Weiss RS, Javier RT, (1997) Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94: 6670-6675.
17. Ronco LV, Karpova AY, Vidal M, Howley PM, (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12: 2061-2072.
18. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA, (2008) E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol 82: 10408-10417.
19. Liu X, Dakic A, Zhang Y, Dai Y, Chen R, et al. (2009) HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proc Natl Acad Sci U S A 106: 18780-18785.
20. Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ, Scheffner M, (2001) Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc Natl Acad Sci U S A 98: 1218-1223.
21. Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, et al. (2003) p29ING4 and p28ING5 Bind to p53 and p300, and Enhance p53 Activity. Cancer Res 63: 2373-2378.
22. Russell M, Berardi P, Gong W, Riabowol K, (2006) Grow-ING, age-ING and die-ING: ING proteins link cancer, senescence and apoptosis. Exp.Cell Res 312: 951-961.
23. Soliman MA, Riabowol K (2007) After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem. Sci 32509-519.
24. Doyon Y, Cayrou C, Ullah M, Landry AJ, Côté V, et al. (2006) ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 21 (2006): 51-64.
25. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, et al. (2004) The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428: 328-332.
26. Ozer A, Wu LC, Bruick RK, (2005) The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci U S A 102: 7481-7486.
27. Unoki M, Kumamoto K, Takenoshita S, Harris CC (2009) Reviewing the current classification of inhibitor of growth family proteins. Cancer Sci 100 1173-1179.
28. Saha A, Bamidele A, Murakami M, Robertson ES, (2011) EBNA3C Attenuates the Function of p53 through Interaction with Inhibitor of Growth Family Proteins 4 and 5. J Virol 85: 2079-2088.
29. Zimmermann H, Degenkolbe R, Bernard HU, O'Connor MJ, (1999) The humanpapillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol 73: 6209-6219.
30. Li J, Martinka M, Li G, (2008) Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis 29: 1373-1379.
31. Sekaric P, Cherry JJ, Androphy EJ, (2008) Binding of human papillomavirus type 16 E6 to E6AP is not required for activation of hTERT. J Virol 82: 71-76.
32. Tsai KW, Tseng HC, Lin WC, (2008) Two wobble-splicing events affect ING4 protein subnuclear localization and degradation. Exp Cell Res 314: 3130-3141.
33. Zhang X, Wang KS, Wang ZQ, Xu LS, Wang QW, et al. (2005) Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem Biophys Res Commun. 331: 1032-1038.
34. Xu S, Jiang B, Hou X, Shi C, Bachschmid MM, et al. (2011) High-fat diet increases and the polyphenol, S17834, decreases acetylation of the sirtuin-1-dependent lysine-382 on p53 and apoptotic signaling in atherosclerotic lesion-prone aortic endothelium of normal mice. J Cardiovasc Pharmacol 58: 263-71.
35. Hebner C, Beglin M, Laimins LA, (2007) Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J Virol 81: 12740-12747.
36. Thomas MC, Chiang CM, (2005) E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell 17: 251-264.
37. Mantovani F, Banks L (2001)The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20 7874-7887.
38. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W, (2008) Acetylation is indispensable for p53 activation. Cell 133: 612-626.